A groundbreaking conservation initiative is taking shape in the United States: a cryogenic repository, dubbed the BioVault, that will store living cells and extracted DNA from roughly 2,300 plant and animal species listed under the Endangered Species Act. The vault operates at an extreme temperature of minus 321°F (approximately minus 196°C), the temperature of liquid nitrogen, allowing biological material to remain viable for decades or even centuries.
Colossal Biosciences, a Texas‑based biotech firm, has partnered with the U.S. Fish and Wildlife Service to build the facility at its Dallas headquarters and additional satellite sites. The goal is to collect tissue samples, reproductive material, and cell lines before populations decline beyond recovery. According to the company’s chief executive, the vault will serve as a permanent public resource, offering standardized samples and genomic data to researchers worldwide.
The potential applications are wide‑ranging. Preserved sperm, eggs, and somatic cells can support assisted reproduction programs, strengthen genetic management of wild populations, and provide a genetic “blueprint” for future restoration projects. In theory, if a species disappears from the wild, scientists could use the stored material to re‑introduce individuals with restored genetic diversity.
While the technology does not replace the need to protect habitats, curb pollution, or address climate change, it adds an essential tool to the conservation toolbox. By safeguarding the genetic information of endangered species, the BioVault offers a safety net that could buy time for broader ecological solutions.
The concept has drawn comparisons to the biblical Noah’s Ark, but with a modern twist: instead of storing whole organisms, the vault preserves the molecular instructions for life. Ben Lamm, CEO of Colossal, emphasizes that “the Noah’s Ark metaphor is about preserving the blueprint of life before it’s lost, not waiting until a species is on the brink to start paying attention.”
Other organizations are already employing similar techniques on a smaller scale. For example, the wildlife charity Nature’s SAFE worked with Bristol Zoo to cryopreserve the sperm and testicular tissue of Jock, a 42‑year‑old western lowland gorilla. Those samples now sit in a biobank, ready to support advanced reproductive technologies that could bolster the species’ dwindling numbers.
Funding for the BioVault is expected to run into tens of millions of dollars, reflecting both the technical challenges of long‑term cryopreservation and the scale of the undertaking. The repository will be built to complement existing conservation efforts, inviting zoos, universities, government agencies, NGOs, and research institutions to contribute samples and share data.
Critics caution that storing DNA alone cannot solve the root causes of biodiversity loss, but many experts argue that the vault provides a unique form of insurance. As habitats continue to fragment and climate pressures intensify, having a well‑cataloged, high‑quality genetic library could be the difference between a species’ permanent extinction and a future revival.
In the coming years, the BioVault will begin receiving samples, starting with species most at risk of rapid decline. Its success could inspire similar initiatives worldwide, establishing a network of cryogenic archives that collectively safeguard the planet’s biological heritage for generations to come.